Christopher Morabito

Business address
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA, 02139
Top holdings (ownership)
ATXS and FULC
Get insider transactions for this reporting owner
Christopher Morabito has filed 13 SEC EDGAR filings since 12 May 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT 25 Mar 2025 21 Mar 2025 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT 03 Apr 2024 01 Apr 2024 001-37467
144 Open Document Open Filing 01 Apr 2024
4 Open Document Open Filing OWNERSHIP DOCUMENT 12 Feb 2024 08 Feb 2024 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT 30 Jan 2024 26 Jan 2024 001-37467
144 Open Document Open Filing 29 Jan 2024
4 Open Document Open Filing OWNERSHIP DOCUMENT 06 Jun 2023 02 Jun 2023 001-37467
4 Open Document Open Filing OWNERSHIP DOCUMENT 02 Aug 2022 01 Aug 2022 001-37467
3 Open Document Open Filing OWNERSHIP DOCUMENT 15 Jul 2022 14 Jul 2022 001-37467
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jan 2022 19 Jan 2022 001-38978
4 Open Document Open Filing FORM 4 SUBMISSION 29 Jun 2021 28 Jun 2021 001-38978
4 Open Document Open Filing FORM 4 SUBMISSION 12 May 2021 10 May 2021 001-38978
3 Open Document Open Filing FORM 3 SUBMISSION 12 May 2021 10 May 2021 001-38978